FDA Requests Removal Of Endo Pharmaceuticals' Opioid Pain Medication: Here's Why

The FDA requested Endo Pharmaceuticals to voluntary remove its pain management drug Opana ER. The agency requested the drug's withdrawal from the market for fear of opioid abuse.